Research analysts at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a "sell...
Trevena (NASDAQ:TRVN - Get Free Report)s stock had its "buy" rating reissued by stock analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They presently have a...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies Company announces reduction of OLINVYK commercial...
Analysts at StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research report issued on Friday. The firm set a "sell" rating on the biopharmaceutical...
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN Free Report) in a research report report published on Monday morning. The brokerage issued a sell rating on the...
Analysts at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN Get Free Report) in a note issued to investors on Sunday. The brokerage set a sell rating on the...
Trevena (NASDAQ:TRVN Get Free Report) and JanOne (NASDAQ:JAN Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies...
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN Free Report) in a report released on Saturday. The brokerage issued a sell rating on the biopharmaceutical companys...